Angel Biotechnology Holdings (LSE:ABH) Market Cap: £1.89 Mil (As of Jun. 30, 2026)


What is Angel Biotechnology Holdings Market Cap?

Angel Biotechnology Holdings LSE:ABH Market Cap is £1.89 Mil as of Jun. 30, 2026. The stock has 2 warning signs investors should review.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Angel Biotechnology Holdings's share price for the quarter that ended in Sep. 2012 was £0.001. Angel Biotechnology Holdings's Shares Outstanding (EOP) for the quarter that ended in Sep. 2012 was 3,773.62 Mil. Therefore, Angel Biotechnology Holdings's market cap for the quarter that ended in Sep. 2012 was £3.77 Mil.

Angel Biotechnology Holdings's quarterly market cap declined from Jun. 2011 (£8.06 Mil) to Mar. 2012 (£5.37 Mil) and declined from Mar. 2012 (£5.37 Mil) to Sep. 2012 (£3.77 Mil).

Angel Biotechnology Holdings's annual market cap increased from Dec. 2009 (£4.32 Mil) to Dec. 2010 (£8.13 Mil) but then declined from Dec. 2010 (£8.13 Mil) to Mar. 2012 (£5.51 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Angel Biotechnology Holdings's Enterprise Value for Today is £1.89 Mil.

Angel Biotechnology Holdings  (LSE:ABH) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Angel Biotechnology Holdings Market Cap Related Terms

Angel Biotechnology Holdings Market Cap Historical Data

* Premium members only.

The historical data trend for Angel Biotechnology Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Angel Biotechnology Holdings Market Cap Chart

Angel Biotechnology Holdings Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec07 Dec08 Dec09 Dec10 Mar12
Market Cap
Get a 7-Day Free Trial Premium Member Only 3.27 1.36 4.32 8.13 5.51

Angel Biotechnology Holdings Semi-Annual Data
Jun05 Dec05 Jun06 Jun07 Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Mar12 Sep12
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.16 7.94 8.06 5.37 3.77

Angel Biotechnology Holdings Market Cap Competitor Comparison

For the Biotechnology subindustry, Angel Biotechnology Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angel Biotechnology Holdings Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Angel Biotechnology Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Angel Biotechnology Holdings's Market Cap falls into.


Angel Biotechnology Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Angel Biotechnology Holdings's Market Cap for the fiscal year that ended in Mar. 2012 is calculated as

Market Cap (A: Mar. 2012 )=Share Price (A: Mar. 2012 )*Shares Outstanding (EOP) (A: Mar. 2012 )
=£0.002*2755.785
=£5.51

Angel Biotechnology Holdings's Market Cap for the quarter that ended in Sep. 2012 is calculated as

Market Cap (Q: Sep. 2012 )=Share Price (Q: Sep. 2012 )*Shares Outstanding (EOP) (Q: Sep. 2012 )
=£0.001*3773.617
=£3.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of £1.89 Mil mean?
Angel Biotechnology Holdings (LSE:ABH) has a Market Cap of £1.89 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Angel Biotechnology Holdings and its competitors.
Is Angel Biotechnology Holdings' Market Cap too high?
Angel Biotechnology Holdings' current Market Cap is £1.89 Mil.
How does Angel Biotechnology Holdings' Market Cap compare to competitors?
Angel Biotechnology Holdings' Market Cap of £1.89 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 119.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.44, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Angel Biotechnology Holdings and its competitors. For the Biotechnology industry, the median Market Cap is 119.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angel Biotechnology Holdings's current Market Cap is £1.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angel Biotechnology Holdings stock overvalued right now?
Angel Biotechnology Holdings (LSE:ABH) has a current Market Cap of £1.89 Mil. The current Market Cap is £1.89 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Angel Biotechnology Holdings (LSE:ABH), the current Market Cap is £1.89 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.